Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

Cork, M.J. orcid.org/0000-0003-4428-2428, Eckert, L., Simpson, E.L. et al. (14 more authors) (2019) Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. Journal of Dermatological Treatment. ISSN 0954-6634

Abstract

Metadata

Authors/Creators:
  • Cork, M.J. https://orcid.org/0000-0003-4428-2428
  • Eckert, L.
  • Simpson, E.L.
  • Armstrong, A.
  • Barbarot, S.
  • Puig, L.
  • Girolomoni, G.
  • de Bruin-Weller, M.
  • Wollenberg, A.
  • Kataoka, Y.
  • Remitz, A.
  • Beissert, S.
  • Mastey, V.
  • Ardeleanu, M.
  • Chen, Z.
  • Gadkari, A.
  • Chao, J.
Copyright, Publisher and Additional Information: © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Keywords: Atopic dermatitis; dupilumab; patient-reported outcomes; quality of life
Dates:
  • Accepted: 23 April 2019
  • Published (online): 9 June 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 28 Aug 2019 15:39
Last Modified: 28 Aug 2019 15:41
Status: Published
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1080/09546634.2019.1612836
Related URLs:

Share / Export

Statistics